Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Stratified, Parallel-group, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of AMG 334 in Women With Hot Flashes Associated With Menopause

NCT01890109 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01890109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01890109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Stratified, Parallel-group, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of AMG 334 in Women With Hot Flashes Associated With Menopause
Lead sponsor
Amgen
Phase
Phase 1
Overall status
Completed
Start date
May 13, 2013
Completion date
March 11, 2014
Enrollment
103 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

vasomotor symptoms; hot flashes